Clinical Trial

Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic Neuralgia

Study acronym: SCL-HZ/PHN
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2025 (before its estimated September 7, 2025 completion). Its status may not reflect the trial's current state.
Summary
In this study, it was aimed to compare the effect of subcutaneous lidocaine injection, which is routinely applied in pain clinic,in patients who present with pain complaints due to acute herpes zoster and post-herpetic neuralgia, and investigate its contribution to preventing the development of post-herpetic neuralgia
Trial Details
NCT Number NCT06882525
Lead Sponsor Ankara City Hospital Bilkent
Conditions Herpes Zoster, Neuralgia, Postherpetic
Enrollment 76 participants
Start Date 2025-03-07
Primary Completion 2025-09-07 (estimated)
Study Completion 2025-12-06 (estimated)
Updated on ClinicalTrials.gov 2025-03-18